1. Home
  2. News
  3. Anatara Lifesciences Ltd
  4. ANR announces Positive Results from Stage 1 of IBS trial
More Anatara Lifesciences Ltd news
Anatara Lifesciences LtdASX: ANR

ANR announces Positive Results from Stage 1 of IBS trial

Sep 28, 2023 at 12:28 AM EDT · Issued by Anatara Lifesciences Ltd

Filed with ASX · Sep 28, 2023 at 12:28 AM EDT · 7 pages · English

On 6ix: 6ix.com/news/anr-announces-positive-results-from-stage-1-of-ibs-trial

Anatara Lifesciences Ltd on 6ix

Story so far

  • IBS clinical trial Stage 1 patients finalisedAug 31, 2023

Earlier from Anatara Lifesciences

  • IBS clinical trial Stage 1 patients finalisedAug 30, 2023
  • Appendix 4E & Audited Financial Statements 30 June 2023Aug 23, 2023
  • $923,235 in R&D tax incentive receivedAug 13, 2023
  • Appendix 4C & Q4 FY23 Activities ReportJul 31, 2023
  • Anatara Update on GaRP Irritable Bowel Syndrome TrialJun 5, 2023

Later from Anatara Lifesciences

  • Anatara IBS trial positive secondary endpoint data analysisOct 16, 2023
  • Webinar Investor PresentationOct 18, 2023
  • Appendix 4C & Q1 FY24 Activities ReportOct 31, 2023
  • Anatara launches a partially underwritten Entitlement OfferNov 2, 2023
  • Cleansing NoticeNov 2, 2023
All Anatara Lifesciences news releases↗

Follow Anatara Lifesciences into a list and get an email when it puts out news.

Follow Anatara Lifesciences
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer